<![CDATA[IncellDx, Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=24697>Wed, 29 Apr 2026 08:49:47 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Premas, IncellDx Ink India Distribution Agreement]]>https://www.newswire.co.kr/newsRead.php?no=863191Thu, 18 Jan 2018 13:40:00 +0900<![CDATA[인셀Dx, 프레마스와 독점공급계약 체결]]>https://www.newswire.co.kr/newsRead.php?no=863192Thu, 18 Jan 2018 13:40:00 +0900<![CDATA[IncellDx Releases CE-IVD Quantitative Single Cell PD-L1 OncoTect iO® Assay]]>https://www.newswire.co.kr/newsRead.php?no=847622Fri, 31 Mar 2017 14:00:00 +0900<![CDATA[인셀Dx, 체외진단의료기기(CE-IVD) 정량 단일세포 PD-L1 OncoTect iO® 분석 발표]]>https://www.newswire.co.kr/newsRead.php?no=847624Fri, 31 Mar 2017 14:00:00 +0900<![CDATA[IncellDx’s Quantitative Immuno-Oncology Assay OncoTect iO Published in New Study]]>https://www.newswire.co.kr/newsRead.php?no=836661Wed, 05 Oct 2016 16:00:00 +0900<![CDATA[인셀Dx의 정량적 면역종약학 분석 OncoTect iO, 학술지 게재]]>https://www.newswire.co.kr/newsRead.php?no=836662Wed, 05 Oct 2016 16:00:00 +0900<![CDATA[IncellDx, Inc. Signs Exclusive License with Claremont BioSolutions to Commercialize Novel Liquid-Based Biopsy Technology]]>https://www.newswire.co.kr/newsRead.php?no=788902Wed, 15 Apr 2015 11:20:00 +0900<![CDATA[인셀Dx, 클레어몬트 바이오솔루션과 액체 기반 생체검사 신기술 상용화 위한 독점 라이선스 체결]]>https://www.newswire.co.kr/newsRead.php?no=788906Wed, 15 Apr 2015 11:20:00 +0900